Complement Component C4a

As a product of complement activation, C4a contributes to various immunological processes and has been the subject of extensive research in recent years. This article will delve into the structure, function, and clinical significance of C4a, highlighting its importance in both health and disease.

Structure of C4a

C4a is a small but significant protein fragment generated during the activation of the complement system. It is released from the alpha chain of C4 during the activation of the classical or lectin pathways of the complement system. In both pathways, activated C1s or mannose-binding lectin-associated serine proteases (MASPs) cleave C4 into two fragments:

• C4b: A larger fragment that covalently binds to microbial surfaces or immune complexes, facilitating further complement activation.
• C4a: A smaller anaphylatoxin fragment released into circulation.

Fig. 1 Molecular model of human C4a.^1,3

C4a is a polypeptide derived from the N-terminal region of the alpha chain. It exhibits unique structural and functional characteristics.

• Size and composition: It is significantly smaller than its parent molecule and lacks enzymatic activity.
• Anaphylatoxin properties: Unlike other complement fragments such as C3b or C5b, which serve as opsonins or membrane attack complex components, C4a functions primarily as an anaphylatoxin. It mediates inflammatory responses through receptor interactions.
• Receptor binding: Recent studies have identified protease-activated receptors PAR1 and PAR4 as specific binding partners for C4a. This distinguishes it from other anaphylatoxins like C3a and C5a, which bind to G protein-coupled receptors such as C3aR and C5aR.

The generation of C4a from its parent molecule represents a critical step in innate immune activation. Its release upon cleavage of C4 highlights its role as both a marker of complement activation and an active mediator in inflammatory responses.

Biological Functions of C4a

C4a, a small protein fragment produced during the activation of the complement system, plays a crucial role in immune regulation and inflammation. Although its activity is less pronounced than other anaphylatoxins like C3a and C5a, C4a has distinct biological functions that contribute to the body's defense mechanisms and homeostasis.

Table 1 Biological functions of C4a.

Fig. 2 Anti-inflammatory functions by complement C4 activation fragments C4a.^2,3

Although biologically active, the functional profile of C4a is notably weaker compared to its counterparts.

• Low potency: In comparative studies, concentrations of C4a required to elicit biological effects are significantly higher than those for C3a or C5a.
• Lack of chemotactic activity: Unlike C3a or C5a, which exhibit strong chemotactic properties for neutrophils and monocytes, C4a shows minimal or no chemotactic activity.

Complement C4a Test

The C4a test is a specialized diagnostic tool used to measure the levels of C4a in human plasma. Elevated levels of C4a are associated with various inflammatory, autoimmune, and infectious conditions, making this test a valuable biomarker.

The C4a test is typically performed using advanced laboratory techniques such as radioimmunoassay (RIA) or enzyme-linked immunosorbent assay (ELISA). These methods provide accurate quantification of plasma C4a levels.

Table 2 Methods of C4a functional assays.

Based on the study results provided, the results of the complement C4 test can be interpreted as follows.

C4a and Disease Pathology

Dysregulation of C4a levels or activity has been implicated in various pathological conditions.

• Autoimmune disorders: Elevated C4a levels have been observed in systemic lupus erythematosus (SLE) and rheumatoid arthritis.
• Inflammatory diseases: Excessive C4a activation may contribute to chronic inflammatory conditions such as asthma and inflammatory bowel disease.
• Neurological disorders: Recent studies suggest a potential role for C4a in neuroinflammation associated with conditions like Alzheimer's disease and multiple sclerosis.

Given its role in inflammation and immune regulation, C4a and its signaling pathways represent potential therapeutic targets.

C4a as a Therapeutic Target

Several strategies for targeting C4a therapeutically are being explored.

• Inhibitors: Developing small molecule inhibitors or antibodies that specifically target C4a or its receptors.
• Gene therapy: Modulating C4A gene expression to normalize complement activity.
• Biologics: Creating biologics that can modulate C4a-mediated inflammatory responses.

While C4a shows promise as a therapeutic target, several challenges remain:

• Specificity: Developing therapies that selectively target C4a without affecting other complement components.
• Delivery: Ensuring targeted delivery to affected tissues, especially in neurological conditions.
• Safety: Balancing complement inhibition to avoid compromising immune function.

As our understanding of C4a grows, it holds the promise of providing new insights into immune regulation and new therapeutic approaches for a wide range of pathological conditions. As we gradually unravel the complexity of the complement system, C4a stands out as a key molecule worthy of continued research and therapeutic exploration.

Creative Biolabs is a global leader in biotechnology solutions, specializing in antibody development, protein engineering and therapeutic discovery. For customized solutions for complement system research, please contact our team of experts.

• Complement Activation Products Test
• Antibodies
• Sera and Plasmas
• Proteins
• Reagents

If you want more information, please feel free to contact us.

References

1. Pasupuleti, Mukesh, et al. "Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans." Journal of Biological Chemistry 282.4 (2007): 2520-2528. https://doi.org/10.1074/jbc.M607848200
2. Wang, Hongbin, and Mengyao Liu. "Complement C4, infections, and autoimmune diseases." Frontiers in immunology 12 (2021): 694928. https://doi.org/10.3389/fimmu.2021.694928
3. under Open Access license CC BY 4.0, without modification.